Interferonγ and interleukin-17 production from ppd-stimulated pbmcss of patients with pulmonary tuberculosis

Clinical and Investigative Medicine

Volumn 36, Issue 2, 2013, Pages

  Nunnari, Giuseppe ^a   Pinzone, Marilia R ^a   Vancheri, Carlo ^a   Palermo, Filippo ^a   Cacopardo, Bruno ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; TUBERCULIN;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TUBERCULIN; TUBERCULOSIS, PULMONARY;

EID: 84877063864     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Flynn JL (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84:93-101.
2. Tufariello JM, Chan J, Flynn JL (2003) Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3:578-590.
3. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon v in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254.
4. Orme IM, Roberts AD, Griffin JP, Abrams JS (1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 151:518-525.
5. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR (1995) Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
6. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Tsai MM, Flynn JL, Chan J (2001) Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847-1855.
7. Rich EA, Torres M, Sada E, Finegan CK, Hamilton BD, Toossi Z (1997) Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber Lung Dis 78:247-255.
8. MacMicking JD, Taylor GA, McKinney JD (2003) Immune control of tuberculosis by IFNγ-inducible LRG-47. Science 302:654-659.
9. Curtis MM, Way SS (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177-185.
10. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226:87-102.
11. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, Anderson IK, Brightling CE (2010) Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138:1140-1147.
12. Wilson NJ, Boniface K, Chan JR, et al. (2007) Development, cytokine profile and function of human interleukin 17- producing helper T cells. Nat Immunol 8:950-957.
13. Volpe E, Servant N, Zollinger R, Bogiatzi Hupé, SI P, Barillot E, Soumelis V (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9:650-657.
14. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17 producing human T helper cells. Nat Immunol 8:942-949.
15. Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC, Skoogh BE, Lindén A (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347-2352.
16. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Walzl G, Gelderbloem SJ, Mahomed H, Hussey GD, Hanekom WA (2008) Distinct, speci fic IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180:1962-1970.
17. Dheda K, Chang JS, Lala S, Huggett JF, Zumla A, Rook GA (2008) Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis. Thorax 63:566-568.
18. Chen X, Zhang M, Liao M, Graner MW, Wu C, Yang Q, Liu H, Zhou B (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J RespirCrit Care Med 181(7):734-742.
19. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM.(2007) IL-23 and IL- 17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369-377.
20. Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, Samten B, Barnes PF (2003) Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 36:24-28.
21. Hirsch CS, Toossi Z, Othieno C, et al. (1999) Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180:2069-2073.
22. Kumar NP, Anuradha R, Suresh R, Ganesh R, Shankar J, Kumaraswami V, Nutman TB, Babu S (2011) Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol 18(11):1856-1864.
23. Sodhi A, Gong J, Silva C, Qian D, Barnes PF (1997) Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis 25:617-620.
24. Dlugovitzky D, Bay ML, Rateni L, Fiorenza G, Vietti L, Farroni MA, Bottasso OA (2000) Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMCs) from patients with pulmonary tuberculosis (TB). ClinExpImmunol 122:343-349.
25. Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J (1994) Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171-176.
26. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM; VACSEL Study Group (2004) Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172:6938-6943.
27. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, Bah B, Benagiano M, Diallo A, Manetti R, Manneh K, Gustafson P, Bennett S, D'Elios MM, McAdam K, Del Prete G. (2002) Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 32:1605-1613.
28. Dlugovitzky D, Bay ML, Rateni L, Urízar L, Rondelli CF, Largacha C, Farroni MA, Molteni O, Bottasso OA (1999) In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 49:210-217.
29. Jurado JO, Pasquinelli V, Alvarez IB, Peña D, Rovetta AI, Tateosian NL, Romeo HE, Musella RM, Palmero D, Chuluyán HE, García VE (2012) IL-17 and IFNγ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J LeukocBiol 91(6):991-1002.
30. Marín ND, París SC, Rojas M, García LF (2012) Reduced Frequency of Memory T Cells and Increased Th17 Responses in Patients with Active Tuberculosis. Clin Vaccine Immunol 19(10):1667-1676.
31. Pasquinelli V, Townsend JC, Jurado JO, Alvarez IB, Quiroga MF, Barnes PF, Samten B, García VE (2009) IFN-gamma Production during Active Tuberculosis Is Regulated by Mechanisms That Involve IL-17, SLAM, and CREB. J Infect Dis 199:661-665.
32. Stern J, Keskin DB, Romero V, Zuniga J, Encinales L, Li C, Awad C, Yunis EJ (2009) Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res 45:1-12.
33. SargentiniV, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, Nisini R (2009) Cytometric detection of antigenspeci fic IFNγ/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis
34. Cowan J, Pandey S, Filion LJ, Angel JB, Kumar A, Cameron DW (2012) Comparison of interferon-g-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin Exp Immunol 167:317-329.
35. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB (2010) Regulatory T Cells Modulate Th17 Responses in Tuberculin skin test positive (TST+) individuals. J Infect Dis 201(1):20-31.
36. Ehlers S (2010) DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur J Cell Biol 89(1): 95-101.